 MINNEAPOLIS, March 31, 2021 GLOBE NEWSWIRE -- Inspire Medical Systems, Inc. NYSE: INSP Inspire, a medical technology company focused on the development and commercialization of innovative and minimally invasive solutions for patients with obstructive sleep apnea, today announced receipt of U.S. Food and Drug Administration FDA approval for the new Inspire physician programmer platform. The most significant enhancement associated with this approval is the new telemetry cable which enables Bluetooth connectivity to the programmer tablet. 